TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
13.29
↓ 100% below average
Average (9y)
5734.51
Historical baseline
Range
High:39471.44
Low:10.38
CAGR
-46.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 13.29 | +28.1% |
| 2023 | 10.38 | -98.2% |
| 2022 | 575.19 | +53.1% |
| 2021 | 375.58 | -99.0% |
| 2020 | 39471.44 | +511.7% |
| 2019 | 6453.25 | +217.0% |
| 2018 | 2035.62 | -39.1% |
| 2017 | 3340.12 | +123.2% |
| 2016 | 1496.53 | -58.1% |
| 2015 | 3573.69 | - |